ITGB3 and myelodysplastic syndrome: Indeed, the apparent overshoot effects of RAP-536 treatment on CD61 expression seen in Fig. 4 would be consistent with the involvement of further TGF-ß superfamily members in limiting hematopoietic support by MDS MSCs.